2024-11-04T15:49:42-06:00 2023-12-31 390919055 RITZ HOLMAN LLP 330 E KILBOURN AVE SUITE 550 MILWAUKEE WI 53202 990 2023-01-01 911766321 THE AMERICAN SOCIETY OF GENE & CELL THERAPY AMER 4142781341 20800 SWENSON DR 300 WAUKESHA WI 53186 FEDERICO MINGOZZI PHD TREASURER 4142781341 2024-11-04 1 1 KATY L SOMMER P00273273 4142711451 2024-11-04 2023 2024-10-15 13:58:12Z FEDERICO MINGOZZI PHD 20800 SWENSON DR 300 WAUKESHA WI 53186 16370708 0 X WWW.ASGCT.ORG X 1996 WA ASGCT'S MISSION IS TO ADVANCE KNOWLEDGE, AWARENESS, AND EDUCATION LEADING TO THE DISCOVERY AND CLINICAL APPLICATION OF GENETIC AND CELLULAR THERAPIES TO ALLEVIATE HUMAN DISEASE. 15 15 45 19 43395 38899 721885 1051877 11558366 14604317 121557 643264 81244 71250 12483052 16370708 997650 1853948 0 0 3383310 4400143 0 0 695273 6577668 7500536 10958628 13754627 1524424 2616081 20486557 23810378 6268459 6597384 14218098 17212994 X ASGCT'S MISSION IS TO ADVANCE KNOWLEDGE, AWARENESS, AND EDUCATION LEADING TO THE DISCOVERY AND CLINICAL APPLICATION OF GENETIC AND CELLULAR THERAPIES TO ALLEVIATE HUMAN DISEASE. 0 0 5946019 60500 9928858 ANNUAL MEETING: THIS IS THE PRIMARY VEHICLE FOR CARRYING OUT THE EDUCATIONAL MISSION OF ASGCT. THE ANNUAL MEETING REPRESENTS THE MAJOR EDUCATIONAL INITIATIVE OF THE SOCIETY. 959925 216736 3165143 MOLECULAR THERAPY JOURNALS: PUBLISHING SCHOLARLY JOURNALS IS THE SECOND MAJOR VEHICLE FOR CARRYING OUT THE EDUCATIONAL MISSION OF ASGCT. THE JOURNALS ARE THE WAY ASGCT EDUCATES AND UPDATES RESEARCHERS, CLINICIANS, AND STUDENTS ON THE LATEST ADVANCES IN THE DEVELOPMENT OF NOVEL THERAPEUTICS. 774362 25000 ADVOCACY: ADVOCACY IS THE THIRD MAJOR VEHICLE FOR CARRYING OUT THE EDUCATIONAL MISSION OF ASGCT. THE DEFINING VALUE OF ADVOCACY IS "GENE AND CELL THERAPY WILL HAVE A FINANCIAL IMPACT ON PATIENTS, PROVIDERS, AND PAYERS. ASGCT IS COMMITTED TO UNDERSTANDING THAT IMPACT AND EDUCATING DECISION-MAKERS ENGAGED IN DEVELOPING POLICIES THAT INFLUENCE PATIENT ACCESS TO TREATMENTS." 3560576 1551712 1538171 OTHER PROGRAMS INCLUDE: WORKSHOPS, INTERNATIONAL ONCOLYTIC VIRUS CONFERENCE, POLICY SUMMIT, CAREER DEVELOPMENT PROGRAM, DIVERSITY AND INCLUSION COMMITTEE, CAREER DEVELOPMENT PROGRAM PATIENT EDUCATION PROGRAM, AND THE NEWSLETTER. 3560576 1551712 1538171 11240882 1 1 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 0 1 0 1 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 105 0 1 45 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 15 15 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 X 501 FINANCIAL MANAGEMENT 8479755304 2549 WAUKEGAN RD 210 BANNOCKBURN IL 60015 BEVERLY DAVIDSON PHD PAST PRESIDENT 5.00 X X 0 0 0 HANS-PETER KIEM MD PHD PAST PRESIDENT 5.00 X X 0 0 0 JEFFREY S CHAMBERLAIN PHD PRESIDENT 5.00 X X 0 0 0 TERENCE R FLOTTE MD VICE PRESIDENT 5.00 X X 0 0 0 PALOMA H GIANGRANDE PHD PART YEAR TREASURER 5.00 X X 0 0 0 ANASTASIA KHVOROVA PHD PART YEAR DIRECTOR 3.00 X 0 0 0 FEDERICO MINGOZZI PHD PART YEAR TREASURER 5.00 X X 0 0 0 HILDEGARD BUNING PHD DIRECTOR 3.00 X 0 0 0 MARCELA V MAUS MD PHD PART YEAR DIRECTOR 3.00 X 0 0 0 MARIA-GRAZIA RONCAROLO MD DIRECTOR 3.00 X 0 0 0 RAYNE H ROUCE MD DIRECTOR 3.00 X 0 0 0 PAULA CANNON PHD PRESIDENT ELECT 5.00 X X 0 0 0 ISABELLE RIVIRE PHD SECRETARY 5.00 X X 0 0 0 ARAVIND ASOKAN PHD DIRECTOR 3.00 X 0 0 0 DANIEL E BAUER MD PHD DIRECTOR 3.00 X 0 0 0 LINDSEY GEORGE MD DIRECTOR 3.00 X 0 0 0 PUNAM MALIK MD DIRECTOR 3.00 X 0 0 0 KAH-WHYE PENG PHD DIRECTOR 3.00 X 0 0 0 JENNIFER WELLMAN MS DIRECTOR 3.00 X 0 0 0 DAVID BARRETT EXECUTIVE DIRECTOR 40.00 X 432985 0 36376 MARGARITA LEA VALDEZ EMPLOYEE 40.00 X 196383 0 5891 GRANT HOLLEY EMPLOYEE 40.00 X 136659 0 10654 LAURA MICHELLE GALLAGHER EMPLOYEE 40.00 X 193488 0 14798 ALEX WENDLAND EMPLOYEE 40.00 X 126061 0 3782 BETTY SCHIEFELBEIN EMPLOYEE 40.00 X 126173 0 3795 1211749 0 75296 6 0 1 0 BGR GOVERNMENT AFFAIRS LLC 601 THIRTEENTH STREET NW 11TH FL WASHINGTON DC 20005 ADVOCACY 198000 MOTIF SEATTLE 1415 5TH AVE SEATTLE WA 98101 CONFERENCE 101980 2 1051877 1051877 REGISTRATIONS 900099 7419074 7419074 JOURNAL INCOME 900099 3165143 3165143 EXHIBIT REVENUE 900099 2740109 2740109 MEMBERSHIP DUES AND ASSESSMENTS 900099 1154028 1154028 ASGCT/ISSCR EVENT 900099 125963 125963 14604317 643264 643264 ADVERTISING 541900 43395 43395 MISCELLANEOUS 541900 25070 25070 JOB POSTING 541900 2785 2785 71250 16370708 14632172 43395 643264 1490000 1490000 324138 324138 39810 39810 469361 305085 93872 70404 3228101 2098265 645620 484216 96024 62415 19205 14404 320698 208454 64140 48104 285959 185873 57192 42894 12115 11415 700 97778 97778 28731 28731 753060 615508 137552 488870 486863 2007 517199 183113 334086 460316 295749 164567 235004 152752 47001 35251 587319 587319 3378914 3345421 33493 55236 55236 88064 72478 15586 DECORATION EXPENSES 411888 411888 REGISTRATION EXPENSE 218525 218525 MEMBERSHIP RECRUIT AND 93480 93480 PROFESSIONAL DEVELOPMEN 43419 35825 7594 30618 16506 14112 13754627 11240882 1818472 695273 4989141 1681611 254004 254513 416894 3532561 199255 298531 456617 178579 79463 92100 99116 10563915 20155555 21487 10767 734818 536050 20486557 23810378 402984 420123 5013719 5534184 851756 643077 6268459 6597384 X 13705286 16221383 512812 991611 14218098 17212994 20486557 23810378 2616081 378815 0 X X 0 1 X 1 0 X 1735740 812176 1168710 1068777 1288905 6074308 4616587 5571192 8027679 11206474 14367289 43789221 6352327 6383368 9196389 12275251 15656194 49863529 85000 95000 180000 0 85000 95000 180000 49683529 100334 84023 115856 121557 643264 1065034 100334 84023 115856 121557 643264 1065034 25200 28400 29400 43189 43395 169584 31407 20419 48028 43055 27855 170764 6509268 6516210 9389673 12483052 16370708 51268911 0.96910 0.96570 0.02080 0.01210 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 232582 22260 254842 311044 -78462 232582 244199 410 66435 311044 208002 1710 34487 244199 158984 1875 47143 208002 1.00000 0 0 178579 79463 99116 99116 LEASE LIABILITY - FINANCE LEASE 4317 LEASE LIABILITY - OPERATING LEASE 638760 643077 X 16720792 378815 378815 16341977 28731 28731 16370708 13725896 0 13725896 28731 28731 13754627 PART V, LINE 4: THE BOARD DESIGNATED ENDOWMENT FUNDS ARE INTENDED TO BE USED IN THE FUTURE TO OFFER RESEARCH GRANT(S) TO A QUALIFIED MEMBER(S) OF ASGCT. PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS CLASSIFIED AS OTHER THAN A PRIVATE FOUNDATION. HOWEVER, INCOME FROM CERTAIN ACTIVITIES, PRIMARILY ADVERTISING, NOT DIRECTLY RELATED TO THE ORGANIZATION'S TAX-EXEMPT PURPOSE IS SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. AS OF DECEMBER 31, 2023, TOTAL UNRELATED BUSINESS INCOME TAX EXPENSE WAS $8,169 WITH $-0- OF INCOME TAX PAYABLE. MANAGEMENT HAS REVIEWED ALL TAX POSITIONS RECOGNIZED IN PREVIOUSLY FILED TAX RETURNS AND THOSE EXPECTED TO BE TAKEN IN FUTURE TAX RETURNS. AS OF DECEMBER 31, 2023, THE ORGANIZATION HAD NO AMOUNTS RELATED TO UNRECOGNIZED INCOME TAX BENEFITS AND NO AMOUNTS RELATED TO ACCRUED INTEREST AND PENALTIES. THE ORGANIZATION DOES NOT ANTICIPATE ANY SIGNIFICANT CHANGES TO UNRECOGNIZED INCOME TAX BENEFITS OVER THE NEXT YEAR. THE ORGANIZATION IS CURRENTLY NOT UNDER AUDIT BY ANY FEDERAL OR STATE TAXING AUTHORITY. 1 EAST ASIA AND THE PACIFIC 0 0 GRANTS AND OTHER ASSISTANCE RESEARCH AWARDS 21280 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 GRANTS AND OTHER ASSISTANCE RESEARCH AWARDS 2125 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS AND OTHER ASSISTANCE RESEARCH AWARDS 3510 CENTRAL AMERICA AND THE CARIBBEAN 0 0 GRANTS AND OTHER ASSISTANCE RESEARCH AWARDS 1690 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS AND OTHER ASSISTANCE RESEARCH AWARDS 11205 0 0 0 0 0 0 39810 0 39810 RESEARCH AWARDS EUROPE (INCLUDING ICELAND & GREENLAND) 10 11205 WIRE FMV RESEARCH AWARDS EAST ASIA AND THE PACIFIC 14 21280 WIRE FMV RESEARCH AWARDS NORTH AMERICA 3 2125 WIRE FMV RESEARCH AWARDS MIDDLE EAST AND NORTH AFRICA 1 3510 WIRE FMV RESEARCH AWARDS CENTRAL AMERICA AND THE CARIBBEAN 1 1690 WIRE FMV 0 0 0 0 0 0 PART I, LINE 2: EACH YEAR ASGCT GIVES EXCELLENCE IN RESEARCH AWARDS TO ASGCT ASSOCIATE MEMBERS WHO RECEIVED THE HIGHEST ABSTRACT SCORES OF THOSE SUBMITTED TO THE ASGCT ANNUAL MEETING. THE SCORES ARE GIVEN THROUGH A PEER REVIEW PROCESS BY THE ABSTRACT REVIEW COMMITTEES. THE AWARDEES RECEIVE A TRAVEL REIMBURSEMENT AWARD (OF $750) TO ATTEND THE ANNUAL MEETING. THE OUTSTANDING NEW INVESTIGATOR AWARDS ARE GIVEN TO UP TO FOUR ASGCT ACTIVE MEMBERS WHO HAVE BEEN NOMINATED BY TWO ASGCT ACTIVE MEMBERS. THE NOMINEES MUST BE SEVEN YEARS OR FEWER FROM THEIR FIRST ASSISTANT PROFESSORSHIP AND BE CONDUCTING INDEPENDENT RESEARCH. THE NOMINATIONS ARE SUBMITTED TO THE ASGCT ADVISORY COUNCIL FOR CONSIDERATION. THE ADVISORY COUNCIL THEN SUBMITS THE RECOMMENDATION TO THE ASGCT BOARD OF DIRECTORS FOR APPROVAL. THE AWARDEES ARE GIVEN A $2,000 CASH AWARD AND PRESENT THEIR WORK DURING THE OUTSTANDING NEW INVESTIGATORS SYMPOSIUM AT THE ASGCT ANNUAL MEETING. THE EDITOR-IN-CHIEF OF THE MOLECULAR THERAPY JOURNAL RECEIVES A $25,000 STIPEND AND EACH ASSOCIATE EDITOR IN CHIEF AND ASSOCIATE EDITORS RECEIVES A STIPEND BASED ON THE NUMBER OF PAPERS THEY HANDLE EACH YEAR FROM ASGCT IN THE LAST QUARTER OF EACH YEAR OF THE POSITION. THE STIPEND AMOUNT IS REVIEWED BY THE BOARD DURING THE BUDGETING PROCESS AND WRITTEN INTO AGREEMENT WITH EACH NEW TERM OF THE EDITOR-IN-CHIEF. 1 BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE 1500 E DUARTE ROAD DUARTE CA 910103000 953432210 501(C)(3) 100000 0 FMV CAREER DEVELOPMENT BOSTON CHILDREN'S HOSPITAL PO BOX 414413 BOSTON MA 02241 042774441 501(C)(3) 200000 0 FMV CAREER DEVELOPMENT COLUMBIA UNIVERSITY PO BOX 29789 GENERAL POST OFFICE NEW YORK NY 10087 135598093 501(C)(3) 100000 0 FMV CAREER DEVELOPMENT FOUNDATION FOR THE NIH 11400 ROCKVILLE PIKE 600 NORTH BETHESDA MD 20852 521986675 501(C)(3) 25000 0 FMV AMP BESPOKE GENE THERAPY CONSORTIUM FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVE NORTH SEATTLE WA 98109 237156071 501(C)(3) 100000 0 CAREER DEVELOPMENT HEALTH RESEARCH INC 150 BROADWAY NO 560 MENANDS NY 12204 141402155 501(C)(3) 100000 0 FMV CAREER DEVELOPMENT LEHIGH UNIVERSITY 526 BRODHEAD AVE BETHLEHEM PA 18015 240795445 501(C)(3) 100000 0 FMV CAREER DEVELOPMENT MAYO CLINIC PO BOX 860334 MINNEAPOLIS MN 55486 416011702 501(C)(3) 100000 0 FMV CAREER DEVELOPMENT NATIONAL CANCER INSTITUTE 9000 ROCKVILLE PIKE BUILDING 31 RM 11A16 BETHESDA MD 20892 520858115 501(C)(3) 100000 0 FMV CAREER DEVELOPMENT NATIONAL INSTITUTES OF HEALTH (NIH) 9000 ROCKVILLE PIKE BETHESDA MD 20892 311575142 15000 0 FMV NCATS GRANT STANFORD UNIVERSITY PO BOX 884253 OFFICE OF RESEARCH ADMINISTRATION LOS ANGELES CA 900884253 941156365 501(C)(3) 100000 0 FMV CAREER DEVELOPMENT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES 405 HILGARD AVE LOS ANGELES CA 90095 956006143 501(C)(3) 100000 0 FMV CAREER DEVELOPMENT UNIVERSITY OF IOWA 201 S CLINTON ST GRANT ACCT OFFICE 2410 UCC IOWA CITY IA 52242 426004813 501(C)(3) 100000 0 FMV CAREER DEVELOPMENT UNIVERSITY OF MASSACHUSETTS CHAN MEDICAL SCHOOL 55 LAKE AVENUE NORTH WORCESTER MA 01655 043167352 501(C)(3) 200000 0 FMV CAREER DEVELOPMENT UNIVERSITY OF MIAMI 1500 SOUTH DIXIE HIGHWAY CORAL GABLES FL 33136 590624458 501(C)(3) 50000 0 FMV CAREER DEVELOPMENT 15 0 RESEARCH AWARDS 97 324138 FMV PART I, LINE 2: EACH YEAR ASGCT GIVES EXCELLENCE IN RESEARCH AWARDS TO ASGCT ASSOCIATE MEMBERS WHO RECEIVED THE HIGHEST ABSTRACT SCORES OF THOSE SUBMITTED TO THE ASGCT ANNUAL MEETING. THE SCORES ARE GIVEN THROUGH A PEER REVIEW PROCESS BY THE ABSTRACT REVIEW COMMITTEES. THE AWARDEES RECEIVE A $500 CASH AWARD AND TRAVEL REIMBURSEMENT AWARD (UP TO $500) TO ATTEND THE ANNUAL MEETING. THE OUTSTANDING NEW INVESTIGATOR AWARDS ARE GIVEN TO UP TO FOUR ASGCT ACTIVE MEMBERS WHO HAVE BEEN NOMINATED BY TWO ASGCT ACTIVE MEMBERS. THE NOMINEES MUST BE SEVEN YEARS OR FEWER FROM THEIR FIRST ASSISTANT PROFESSORSHIP AND BE CONDUCTING INDEPENDENT RESEARCH. THE NOMINATIONS ARE SUBMITTED TO THE ASGCT ADVISORY COUNCIL FOR CONSIDERATION. THE ADVISORY COUNCIL THEN SUBMITS THE RECOMMENDATION TO THE ASGCT BOARD OF DIRECTORS FOR APPROVAL. THE AWARDEES ARE GIVEN A $1,000 CASH AWARD AND PRESENT THEIR WORK DURING THE OUTSTANDING NEW INVESTIGATORS SYMPOSIUM AT THE ASGCT ANNUAL MEETING. THE EDITOR-IN-CHIEF OF THE MOLECULAR THERAPY JOURNAL RECEIVES A $25,000 STIPEND AND EACH DEPUTY EDITOR RECEIVES A $5,000 STIPEND FROM ASGCT IN THE LAST QUARTER OF EACH YEAR OF THE POSITION. THE STIPEND AMOUNT IS REVIEWED BY THE BOARD DURING THE BUDGETING PROCESS AND WRITTEN INTO AGREEMENT WITH EACH NEW TERM OF THE EDITOR-IN-CHIEF. X X X 0 0 0 0 0 0 0 0 0 DAVID BARRETT EXECUTIVE DIRECTOR 432985 0 0 0 0 0 9900 0 26476 0 469361 0 0 0 LAURA MICHELLE GALLAGHER EMPLOYEE 193488 0 0 0 0 0 5875 0 8923 0 208286 0 0 0 MARGARITA LEA VALDEZ EMPLOYEE 196383 0 0 0 0 0 5891 0 0 0 202274 0 0 0 FORM 990, PART VI, SECTION A, LINE 6 LINE 6 EXPLANATION - MEMBERSHIP IN THE SOCIETY IS DEPENDENT ON THE APPLICANT ADEQUATELY DEMONSTRATING COMPLIANCE WITH THE REQUIREMENTS FOR MEMBERSHIP AS DEFINED IN THE BYLAWS AND OTHERWISE BY THE BOARD OF DIRECTORS OF THE SOCIETY. THE MEMBERS OF THE SOCIETY ARE (A) MEMBERS: INDIVIDUALS WHO HAVE MANIFESTED AN INTEREST IN ANY DISCIPLINE IMPORTANT TO GENE THERAPY, CELL THERAPY, OR MANUFACTURING TECHNOLOGIES FOR GENE AND CELL DELIVERY AS EVIDENCED BY WORK IN THE FIELD, (B) ASSOCIATE MEMBERS: INDIVIDUALS WHO ARE CURRENTLY ENROLLED IN AN UNDERGRADUATE PROGRAM, POSTDOCTORAL FELLOWS PROGRAM OR GRADUATE STUDIES PROGRAM OR WHO ARE CURRENTLY EMPLOYED AS A LABORATORY MANAGER, TECHNICIAN, ASSISTANT, OR ANY OTHER CLERICAL LABORATORY POSITION IN GENE AND CELL THERAPY RESEARCH PROGRAMS ARE ELIGIBLE FOR ASSOCIATE MEMBERSHIP IN THE SOCIETY (C) REDUCED DUES MEMBERS: INDIVIDUALS WHO RESIDE IN COUNTRIES DESIGNATED AS "LOW INCOME OR "LOWER-MIDDLE INCOME" BY THE WORLD BANK (BASED ON GROSS NATIONAL INCOME PER CAPITA) AND WHO OTHERWISE FULFILL THE REQUIREMENTS FOR MEMBER OR ASSOCIATE MEMBER STATUS SHALL BE ELIGIBLE FOR REDUCED DUES- MEMBER OR REDUCED DUES-ASSOCIATE MEMBER STATUS. (D) TRANSITIONAL MEMBERS: INDIVIDUALS WHO FULFILL THE REQUIREMENTS OF MEMBER SHALL BE ELIGIBLE FOR TRANSITIONAL MEMBERSHIP FOR NO MORE THAN TWO (2) YEARS, WHICH STATUS PROVIDES FOR THE SAME PRIVILEGES AND MEMBER BENEFITS AS A MEMBER EXCEPT THAT MEMBERSHIP DUES SHALL BE AT A DISCOUNTED RATE AS DETERMINED BY THE BOARD OF DIRECTORS. (E) EMERITUS MEMBERS: ANY MEMBER OF THE SOCIETY WHO HAS BEEN IN GOOD STANDING FOR THE MOST RECENT THREE CONSECUTIVE YEARS, UPON ATTAINING AGE SIXTY-FIVE (65), AND RETIREMENT FROM ACTIVE PRACTICE OR RESEARCH REQUEST THAT HIS OR HER MEMBERSHIP STATUS BE TRANSITIONED TO EMERITUS MEMBERSHIP BY MAKING WRITTEN APPLICATION TO THE CHAIR OF THE MEMBERSHIP COMMITTEE. FORM 990, PART VI, SECTION A, LINE 7A LINE 7A EXPLANATION - ACTIVE MEMBERS IN GOOD STANDING SHALL BE ENTITLED TO VOTE ON ALL MATTERS TO BE VOTED ON BY MEMBERS OF THE SOCIETY, INCLUDING, WITHOUT LIMITATION, ELECTING OFFICERS AND DIRECTORS OF THE SOCIETY. ANY MATTER TO BE DECIDED BY A VOTE OF MEMBERS SHALL, EXCEPT AS OTHERWISE PROVIDED IN THE BYLAWS OR IN CHAPTER 24.03RCW OF THE WASHINGTON NONPROFIT CORPORATION ACT (OR ANY SUCCESSOR PROVISION), BE DECIDED BY MAJORITY VOTE OF MEMBERS PRESENT IN PERSON OR BY PROXY AT A MEETING OF THE MEMBERS. ASSOCIATE MEMBERS AND EMERITUS MEMBERS OF THE SOCIETY SHALL NOT HAVE VOTING RIGHTS. FORM 990, PART VI, SECTION A, LINE 7B LINE 7B EXPLANATION - SEE DESCRIPTION IN 7A. FORM 990, PART VI, SECTION B, LINE 11B LINE 11B EXPLANATION - THE FORM 990 AND ALL REQUIRED SCHEDULES ARE PROVIDED TO THE FINANCE COMMITTEE AND BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. ONCE APPROVED THE FORM IS SIGNED BY THE APPROPRIATE OFFICER AND FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C PRIOR TO EACH MEETING OF THE BOARD OF DIRECTORS, EACH DIRECTOR IS ASKED TO REVIEW THE MEETING AGENDA AND MEETING MATERIALS. AFTER REVIEWING, EACH DIRECTOR IS ASKED TO DISCLOSE ANY CONFLICT OF INTEREST TO THE SOCIETY'S EXECUTIVE DIRECTOR. THE EXECUTIVE DIRECTOR DISCUSSES THE CONFLICT WITH THE EXECUTIVE COMMITTEE TO DETERMINE THE APPROPRIATE REMEDIAL ACTION BASED ON THE DISCLOSED CONFLICT. SPEAKERS PRESENTING AT A SOCIETY MEETING ARE REQUIRED TO FILL OUT A DISCLOSURE DOCUMENT AND A FACULTY COMPLIANCE DOCUMENT PRIOR TO SPEAKING. THE DOCUMENTS ARE REVIEWED BY THE SOCIETY. ANY SPEAKERS WHO HAVE A CONFLICT ARE ALSO REQUIRED TO SUBMIT THEIR PRESENTATION SLIDES FOR REVIEW AND INCLUDE A DISCLOSURE SLIDE PRIOR TO THEIR PRESENTATION SO THAT THE AUDIENCE IS AWARE OF THE RELATIONSHIPS THEY HAVE TO DISCLOSE. THE SOCIETY PRODUCES AND DISTRIBUTES TO EACH PROGRAM ATTENDEE A PRINTED DISCLOSURE DOCUMENT THAT COMPLIES ANY DISCLOSURES OF EVERY FACULTY MEMBER. THE SOCIETY ALSO DISTRIBUTES TWO SURVEYS AT EACH PROGRAM: ONE TO THE CHAIR OF THE SESSION AND ONE TO EACH AUDIENCE MEMBER WHICH ASKS THEM TO INDICATE IF THE PRESENTATIONS BY ANY OF THE FACULTY CONTAINED BIAS. FORM 990, PART VI, SECTION B, LINE 15 IN 2020, WE RELIED ON THE ADVICE OF AN INDEPENDENT CONSULTANT (WESTMAN & ASSOCIATES) TO ASSESS ALL NEWLY CREATED POSITIONS AND DETERMINE MARKET RATE BASED ON SEVERAL DATA, INCLUDING ASSOCIATION FORUM AND ASAE SALARY DATA. WE THEN USED THIS MARKET RATE DATA TO SET INDIVIDUAL SALARIES. FORM 990, PART VI, SECTION C, LINE 19 ASGCT MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FORM 990/990-T AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. ALL SUCH REQUESTS SHOULD BE IN WRITING AND ACCOMPANIED BY A $20 REPRODUCTION AND HANDLING CHARGE IF PRINT COPY IS REQUESTED. MEMBERS OF THE BOARD RECEIVING AN INQUIRY MUST ADVISE STAFF OF THE REQUEST WITHIN A REASONABLE TIME AFTER THE INQUIRY IS RECEIVED. THE BYLAWS CAN ALSO BE FOUND ON THE ASGCT WEBSITE. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.